...
首页> 外文期刊>Breast Cancer Research and Treatment >Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model
【24h】

Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model

机译:小鼠乳腺癌模型中CD4 + 和CD8 + T细胞过继转移后肿瘤基质密度与预后相关

获取原文
获取原文并翻译 | 示例

摘要

Adoptive immunotherapy shows promise for the treatment of cancer; however, partial or mixed responses remain common outcomes due to the heterogeneity of tumours. We studied three murine mammary tumour lines that express an ovalbumin-tagged version of HER-2eu and reproducibly undergo complete regression (CR), partial regression (PR), or progressive disease (PD) after adoptive transfer of ovalbumin-specific CD8+ (OT-I) and CD4+ (OT-II) T cells. The three tumour lines were implanted in immunocompetent C57Bl/6 host mice, and established tumours were treated by adoptive transfer of naive OT-I and OT-II T cells. Tumours of the CR and PR classes triggered almost indistinguishable T cell responses in terms of activation, proliferation, trafficking to the tumour site, infiltration of tumour stroma, and intratumoural T cell proliferation; however, tumours of the PR class showed reduced infiltration of tumour epithelium by donor T cells. PD responses were associated with early impairment of T cell activation and proliferation in draining lymph node, followed by negligible infiltration of tumour tissue by donor T cells. Histopathological determinants of outcome were investigated through an unsupervised analysis of 64 untreated tumours representing the three response classes. Tumours of the CR class had proportionately more stroma, which had a looser, more collagen-rich histological appearance. Thus, the amount and composition of tumour stroma distinguished successfully (CR) from unsuccessful (PR or PD) outcomes after adoptive T cell transfer, a finding that might facilitate the design of immunotherapy trials for human breast cancer.
机译:过继免疫疗法显示出有望治疗癌症的前景。然而,由于肿瘤的异质性,部分或混合反应仍然是常见的结果。我们研究了三种表达HER-2 / neu的卵白蛋白标记版本并在过继转移卵白蛋白特异的CD8后可重复经历完全消退(CR),部分消退(PR)或进行性疾病(PD)的小鼠乳腺肿瘤细胞系。 sup> + (OT-I)和CD4 + (OT-II)T细胞。将这三种肿瘤系植入具有免疫能力的C57Bl / 6宿主小鼠中,并通过过继转移天然OT-I和OT-II T细胞来治疗已建立的肿瘤。就激活,增殖,向肿瘤部位的转运,肿瘤基质的浸润和肿瘤内T细胞增殖而言,CR和PR类肿瘤几乎触发了几乎不可区分的T细胞反应。然而,PR类肿瘤显示供体T细胞对肿瘤上皮的浸润减少。 PD反应与引流淋巴结中T细胞活化和增殖的早期损伤有关,随后供体T细胞对肿瘤组织的浸润可忽略不计。通过无监督分析代表三种反应类别的64种未经治疗的肿瘤,研究了结局的组织病理学决定因素。 CR类肿瘤的间质比例更高,其组织学外观更宽松,胶原蛋白含量更高。因此,在过继T细胞转移后,肿瘤基质的数量和组成成功地(CR)与未成功(PR或PD)的结果区分开,这一发现可能有助于设计针对人类乳腺癌的免疫疗法试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号